Table 4.
Risk Factors for Repeated Gastrointestinal Bleeding or Continued Iron Supplementation During the First Year of Follow-up After Multiphase Computed Tomographic Enterography and Other Strategiesa,b
|
Procedure |
Result | Future bleeding or iron supplementation | Odds ratio (95% CI) |
|---|---|---|---|
| mpCTE | Negative | 187/308 (60.7) | 1.91 (1.28-2.86) |
| Positive mpCTE (Ref) | |||
| Capsule endoscopy | Positive | 67/96 (69.8) | 1.88 (0.92-3.84) |
| Negative capsule endoscopy (Ref) | |||
| Surgery | Not done | 236/394 (59.9) | 4.37 (2.31-8.29) |
| Surgery done (Ref) | |||
| BAE | Done | 63/99 (63.6) | 1.53 (0.96-2.42) |
| BAE not performed (Ref) | |||
| BAE diagnosis | Negative or different from mpCTE | 49/70 (70.0) | 2.50 (1.03-6.09) |
| BAE diagnosis same as mpCTE (Ref) | |||
| BAE treatment | Done | 36/48 (75.0) | 2.67 (1.14-6.26) |
| BAE no treatment (Ref) |
a
BAE = balloon-assisted enteroscopy; mpCTE = multiphase computed tomographic enterography; Ref = reference.
b
Data are presented as No. (percentage) of patients.